147 related articles for article (PubMed ID: 3772804)
1. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
Narumiya S; Fukushima M
J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
[TBL] [Abstract][Full Text] [Related]
2. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
Narumiya S; Ohno K; Fujiwara M; Fukushima M
J Pharmacol Exp Ther; 1986 Nov; 239(2):506-11. PubMed ID: 3772805
[TBL] [Abstract][Full Text] [Related]
3. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.
Narumiya S; Ohno K; Fukushima M; Fujiwara M
J Pharmacol Exp Ther; 1987 Jul; 242(1):306-11. PubMed ID: 3302206
[TBL] [Abstract][Full Text] [Related]
4. Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition.
Narumiya S; Fukushima M
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():972-5. PubMed ID: 2960214
[No Abstract] [Full Text] [Related]
5. [Development of antineoplastic prostaglandins].
Fukushima M
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1930-5. PubMed ID: 6577812
[TBL] [Abstract][Full Text] [Related]
6. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
Ohno K; Sakai T; Fukushima M; Narumiya S; Fujiwara M
J Pharmacol Exp Ther; 1988 Apr; 245(1):294-8. PubMed ID: 3361448
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.
Bhuyan BK; Adams EG; Badiner GJ; Li LH; Barden K
Cancer Res; 1986 Apr; 46(4 Pt 1):1688-93. PubMed ID: 3456266
[TBL] [Abstract][Full Text] [Related]
8. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition.
Narumiya S; Fukushima M
Biochem Biophys Res Commun; 1985 Mar; 127(3):739-45. PubMed ID: 3857041
[TBL] [Abstract][Full Text] [Related]
9. Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.
Khan SH; Sorof S
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9401-5. PubMed ID: 2251282
[TBL] [Abstract][Full Text] [Related]
10. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism.
Hughes-Fulford M; Fukushima M
Life Sci Adv Exp Clin Endocrinol; 1993; 12():57-64. PubMed ID: 11539936
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the proliferation of transformed epidermal cells in culture by various prostaglandins.
Ikai K; Ujihara M; Kashihara M; Fukushima M
J Invest Dermatol; 1987 Jul; 89(1):69-72. PubMed ID: 2439606
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells.
Kim IK; Lee JH; Sohn HW; Kim HS; Kim SH
FEBS Lett; 1993 Apr; 321(2-3):209-14. PubMed ID: 8477853
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition.
Ohno K; Fujiwara M; Fukushima M; Narumiya S
Biochem Biophys Res Commun; 1986 Sep; 139(2):808-15. PubMed ID: 3464277
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
Kato T; Fukushima M; Kurozumi S; Noyori R
Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
[TBL] [Abstract][Full Text] [Related]
15. Effect of glutathione content on cellular uptake and growth inhibitory activity of prostaglandin A2 in L-1210 cells.
Ohno K; Hirata M; Narumiya S; Fukushima M
Eicosanoids; 1992; 5(2):81-5. PubMed ID: 1449820
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human gingival carcinoma cell growth by prostaglandins.
Suzuki K; Kobayashi N; Moriya Y; Abiko Y; Suzuki H
Gen Pharmacol; 1988; 19(2):273-6. PubMed ID: 3162424
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Bregman MD; Funk C; Fukushima M
Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation.
Chistyakov DV; Grabeklis S; Goriainov SV; Chistyakov VV; Sergeeva MG; Reiser G
Biochem Biophys Res Commun; 2018 Jun; 500(2):204-210. PubMed ID: 29634926
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
D'Onofrio C; Franzese O; De Marco A; Bonmassar E; Amici C
Leukemia; 1994 Jun; 8(6):1045-56. PubMed ID: 7516027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
